EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Analysis of scientific publications related to Hepatitis B prevention in the last decade: 2013-2023

Anoucheka Julien, Antonio Rosa de Sousa Neto, Ana Raquel Batista de Carvalho, Daniela Reis Joaquim de Freitas, Luana Kelle Batista Moura, Maria Eliete Batista Moura, Simone Maria Muniz da Silva Bezerra, Rosilane de Lima Brito Magalhães

Revista Prevenção de Infecção e Saúde · 2024

DOI: 10.26694/repis.v10i1.5494 ↗
AbstractBibliografische Angaben

Abstract

Introduction: The World Health Organization estimates that chronic infection with the Hepatitis B Virus globally affects approximately 296 million individuals, with 1.5 million new infections yearly. Those affected often remain asymptomatic for extended periods but may inadvertently transmit Hepatitis B Virus to others. Aim: To analyze scientific publications related to the prevention of hepatitis B from 2013 to 2023. Outlining: A bibliometric study with a quantitative approach analyzing 333 articles using the Bibliometrix R package and its web interface Biblioshiny. Results: Articles were predominantly published in 2018 and 2019, with the Journal of Viral Hepatitis being the primary scientific journal. These articles were authored by 2,467 individuals from 810 institutions, emphasizing Udice - French Research Universities. Among the 81 countries identified, China figured prominently. The articles accumulated a total of 8,964 citations. The KeyWords Plus™ highlighted a focus on infection and its transmission pathways, notably vertical/perinatal, immunization against infection, and treatment using antiretrovirals. Implications: The need for new studies focused on educational interventions related to hepatitis B prevention was identified, including the creation, application, and evaluation of educational technologies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →